Evaluation of fluorophore-tethered platinum complexes to monitor the fate of cisplatin analogs.
Evaluation of fluorophore-tethered platinum complexes to monitor the fate of cisplatin analogs.
复制标题
DOI:
10.1007/s00775-015-1290-2
复制
发表时间:
2015-10
影响因子:
3
通讯作者:
Hall, Matthew D.
中科院分区:
文献类型:
--
作者:
Jagodinsky, Justin C.;Sulima, Agnieszka;Cao, Yiqi;Poprawski, Joanna E.;Blackman, Burchelle N.;Lloyd, John R.;Swenson, Rolf E.;Gottesman, Michael M.;Hall, Matthew D.
The platinum drugs cisplatin, carboplatin, and oxaliplatin are highly utilized in the clinic and as a consequence have been extensively studied in the laboratory setting, sometimes by generating fluorophore-tagged analogs. Here, we synthesized two Pt(II) complexes containing ethane-1,2-diamine ligands linked to a BODIPY fluorophore, and compared their biological activity with previously reported Pt(II) complexes conjugated to carboxyfluorescein and carboxyfluorescein diacetate. The cytotoxicity and DNA-damage capacity of Pt-fluorophore complexes was compared to cisplatin, and the Pt-BODIPY complexes were found to be more cytotoxic with reduced cytotoxicity in cisplatin-resistant cells. Microscopy revealed a predominately cytosolic localization, with nuclear distribution at higher concentrations. Spheroids grown from parent and resistant cells revealed penetration of Pt-BODIPY into spheroids, and retention of the cisplatin-resistant spheroid phenotype. While most activity profiles were retained for the Pt-BODIPY complexes, accumulation in resistant cells was only slightly affected, suggesting that some aspects of Pt-fluorophore cellular pharmacology deviate from cisplatin.
登录
查看更多内容
影响因子:
8.8
作者:
Jones, A C;Stratford, I J;Wilson, P A;Peckham, M J
通讯作者:
Peckham, M J
影响因子:
3.4
作者:
Fischer, Stephanie J.;Benson, Linda M.;Windebank, Anthony J.
通讯作者:
Windebank, Anthony J.
影响因子:
3
作者:
DURAND, RE
通讯作者:
DURAND, RE
影响因子:
3
作者:
Hall, MD;Dillon, CT;Hambley, TW
通讯作者:
Hambley, TW
影响因子:
2.4
作者:
Huang, ZH;Huang, YG
通讯作者:
Huang, YG